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Diabetes leads to dysfunction of the neural retina before and independent of classical microvascular diabetic retinopathy, but previous
studies have failed to demonstrate which neurons and circuits are affected at the earliest stages. Here, using patch-clamp recording and
two-photon Ca 2! imaging in rat retinal slices, we investigated diabetes-evoked changes in a microcircuit consisting of rod bipolar cells
and their dyad postsynaptic targets, AII and A17 amacrine cells, which play an essential role in processing scotopic visual signals. AII
amacrines forward their signals to ON- and OFF-cone bipolar cells and A17 amacrines provide GABAergic feedback inhibition to rod
bipolar cells. Whereas Ca 2!-permeable AMPA receptors mediate input from rod bipolar cells to both AII and A17 amacrines, diabetes
changes the synaptic receptors on A17, but not AII amacrine cells. This was expressed as a change in pharmacological properties and
single-channel conductance of the synaptic receptors, consistent with an upregulation of the AMPA receptor GluA2 subunit and reduced
Ca 2! permeability. In addition, two-photon imaging revealed reduced agonist-evoked influx of Ca 2! in dendritic varicosities of A17
amacrine cells from diabetic compared with normal animals. Because Ca 2!-permeable receptors in A17 amacrine cells mediate synaptic
release of GABA, the reduced Ca 2! permeability of these receptors in diabetic animals leads to reduced release of GABA, followed by
disinhibition and increased release of glutamate from rod bipolar cells. This perturbation of neuron and microcircuit dynamics can
explain the decreased dynamic range and sensitivity of scotopic vision that has been observed in diabetes.
Key words: amacrine cells; calcium-permeable AMPA receptors; diabetes; retina
Introduction
Dysfunction of ion channels and receptors important for synap-
tic communication is thought to be at the core of deficits associ-
ated with neuropathological disorders, such as Alzheimer’s
disease, Parkinson’s disease, schizophrenia, and autism (Sheng et
al., 2012; Zoghbi and Bear, 2012). However, establishing causal
links between a specific molecular pathology, the consequent mi-
crocircuit dysfunction, and the ultimate neurological impair-
ment is challenging. Thus, it is advantageous to directly study
physiological signaling within identified neural microcircuits and
well defined animal disease models.
There is increasing evidence that a major complication of di-
abetes mellitus, diabetic retinopathy, partially reflects a dysfunc-
tion of the neural retina that precedes the microvascular
pathology associated with later stages of the disease (Antonetti et
al., 2012; Simó and Hernández, 2014). In this sense, prevascular
diabetic retinopathy reflects a primary neuropathological disor-
der with evidence for changes in the functional state of several
neurotransmitter systems, including levels of glutamate and
GABA, and the expression of AMPA receptor (AMPAR) subunits
(Ng et al., 2004; Ramsey et al., 2006, 2007; Santiago et al., 2006,
2008; Semkova et al., 2010; Gowda et al., 2011; Castilho et al.,
2012). Of particular interest is the regulation of the AMPAR
GluA2 subunit, which is a key determinant of functional proper-
ties of AMPARs (including Ca 2! permeability, single-channel
conductance and kinetics; Cull-Candy et al., 2006; Traynelis et
al., 2010) and has been implicated in neurodegenerative disor-
ders (Weiss, 2011). Although the majority of AMPARs in the
retina are likely to contain GluA2 and thus display low Ca 2!
permeability, receptors with significant Ca 2! permeability are
found in several cell types and contribute to normal synaptic trans-
mission (Diamond, 2011). It is a considerable challenge, however, to
establish a mechanistic connection between diabetes-evoked
changes at the molecular level and visual dysfunction detected in
diabetic patients or animals.
Here, by using an experimental model of diabetes in ma-
ture rats and directly studying synaptic transmission in an
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identified retinal microcircuit, we have examined how diabe-
tes differentially affects the functional properties of synaptic
AMPARs expressed by two well characterized rod amacrine cells
(AII and A17; Fig. 1A), giving rise to marked changes in micro-
circuit functional dynamics. These amacrine cells constitute the
dyad postsynaptic targets in the glutamatergic rod bipolar cell
(RBC) microcircuit (Kolb and Famiglietti, 1974), with AII ama-
crines providing scotopic signals to ON- and OFF-channels (Demb
and Singer, 2012; Hartveit and Veruki, 2012) and A17 amacrines
providing reciprocal inhibition to RBCs (Diamond and Grimes,
2014). Whereas Ca2!-permeable AMPARs (CP-AMPARs) are in-
volved in mediating synaptic input from RBCs to both AII and
A17 amacrines (Singer and Diamond, 2003; Chávez et al., 2006;
Osswald et al., 2007; Bowie, 2012), only the receptors of A17
amacrines are affected by diabetes, and the observed changes are
consistent with an upregulation of the GluA2 subunit and a con-
sequent reduction of Ca 2! permeability. Because CP-AMPARs
in A17 amacrines mediate synaptic release of GABA (Chávez et al.,
2006), the reduced Ca2! permeability of these receptors diminishes
the release of GABA, leading to disinhibition of RBCs and increased
glutamate release from these cells.
Materials and Methods
Retinal slice preparation and visual targeting of neurons. General aspects of
the methods were previously described in detail (Veruki et al., 2003).
Female albino rats (Wistar HanTac; 5– 8 weeks postnatal) were deeply
anesthetized with isoflurane in oxygen and killed by cervical dislocation
(procedure approved under the surveillance of
the Norwegian Animal Research Authority).
Vertical retinal slices were visualized using ei-
ther an Axioskop 2 FS (Zeiss) with a 40"
water-immersion objective and infrared differ-
ential interference contrast (IR-DIC) videomi-
croscopy or an Olympus BX51WI with a 40"
or 60" water-immersion objective and IR-
DIC or IR Dodt gradient contrast videomicros-
copy (Luigs & Neumann). For experiments
with two-photon microscopy, the slices were vi-
sualized using a custom-modified “Movable Ob-
jective Microscope” (MOM; Sutter Instrument)
with a 20" water-immersion objective (0.95 NA;
Olympus) and IR (780 nm LED; M780L2; Thor-
labs) Dodt gradient contrast videomicroscopy.
Recordings were performed at room tempera-
ture (22#25°C).
AII amacrines were targeted based on the
position of a cell body across the border of the
inner nuclear layer (INL) and the inner plexi-
form layer (IPL), and the presence of a thick
primary dendrite that tapers as it descends into
the IPL (Fig. 1B). A17 amacrines were targeted
based on the location of a dome-shaped cell
body at the border of the INL and IPL (Fig. 1B).
RBCs were targeted based on the location of a
cell body at the distal end of the INL, close to
the outer plexiform layer (Fig. 1C). For un-
equivocal identification, all cells were visual-
ized with fluorescence microscopy following
the recording (Fig. 1D–F ). Altogether, we re-
corded from 86 AII amacrine cells (41 normal,
37 diabetic, 8 insulin-treated diabetic), 26 A17
amacrine cells (12 normal, 14 diabetic), and 19
RBCs (10 normal, 9 diabetic).
Solutions and drug application. The standard
extracellular bath solution was continuously
bubbled with 95% O2–5% CO2 and had the
following composition (in mM): 125 NaCl, 25
NaHCO3, 2.5 KCl, 2.5 CaCl2, 1 MgCl2, 10 glu-
cose, pH 7.4. For AII amacrine cells, recording pipettes were filled
with the following (in mM): 125 potassium gluconate, 8 KCl, 5
HEPES, 1 CaCl2, 1 MgCl2, 5 EGTA, 4 Na2ATP, and 2 N-(2,
6-dimethylphenylcarbamoylmethyl)triethylammonium bromide (QX-
314; Tocris Bioscience). pH was adjusted to 7.3 with KOH. In some
recordings, the bath solution contained 0.15 mM CaCl2 and 3.35 mM
MgCl2 to reduce the frequency of spontaneous EPSCs (spEPSCs). For
A17 amacrine cells, pipettes were filled with the following (in mM): 125
potassium gluconate, 8 NaCl, 5 KCl, 10 HEPES, 0.2 EGTA, 4 magnesium
ATP (MgATP), and 0.4 sodium GTP. pH was adjusted to 7.3 with KOH.
For RBCs, pipettes were filled with the following (in mM): 125 CsCl, 8
NaCl, 10 HEPES, 1 CaCl2, 5 EGTA, 15 TEA-Cl, and 4 MgATP. pH was
adjusted to 7.3 with CsOH. For visualization with fluorescence micros-
copy after the recording, we added either Lucifer yellow (1 mg/ml;
Sigma-Aldrich), Alexa Fluor 488 (100 !M; Invitrogen) or Alexa Fluor 594
(40 !M; Invitrogen) to the intracellular solutions. For two-photon Ca 2!
imaging in A17 amacrine cells, pipettes were filled with the A17 solution
indicated above, but EGTA was replaced with Oregon Green 488
BAPTA-1 (OGB-1; 200 !M; Invitrogen) and Alexa Fluor 594 (40 !M) was
added for visualization of the cellular morphology. The data acquisition
software (PatchMaster; HEKA Elektronik) corrected all holding poten-
tials for liquid junction potentials on-line. Theoretical liquid junction
potentials were calculated with JPCalcW (Molecular Devices).
Drugs were added directly to the extracellular solution at the following
concentrations (supplied by Tocris Bioscience, unless otherwise indi-
cated): 1 !M strychnine (Research Biochemicals), 10 !M (-)-bicuculline
methochloride, 0.3 !M tetrodotoxin (TTX), 100 or 200 !M (1,2,5,6-
tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA), 10 !M
Figure 1. Rod amacrine (AII and A17) and RBCs in the rat retinal slice preparation. A, Schematic diagram of retinal microcircuit
consisting of an RBC and AII and A17 amacrine cells, henceforth referred to as the RBC-AII-A17 microcircuit. Arrows indicate
direction and sign of synaptic transmission between the various cellular elements: feedforward glutamatergic transmission from
RBCs to AII and A17 amacrines (solid arrows) and feedback GABAergic transmission from A17 amacrine to RBC (reciprocal synapse;
open arrow). B, IR-DIC videomicrograph of a retinal slice with cell bodies of an A17 (asterisk) and an AII (star) amacrine cell, both
located at the border between the inner nuclear layer and the inner plexiform layer. Scale bar, 10 !m. C, IR-DIC videomicrograph
of a retinal slice with cell body of a RBC (targeted by patch pipette). Same scale as in B. D, AII amacrine cell filled with Alexa Fluor
488 via patch pipette. Maximum intensity projection (along z-axis) generated from wide-field fluorescence image stack after
deconvolution (D–F ). E, A17 amacrine cell filled with Alexa Fluor 488 via patch pipette. F, RBC filled with Alexa Fluor 594 via patch
pipette. Scale bars: D–F, 10 !m .
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N, N,H,-trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-
pentanaminiumbromide hydrobromide (IEM 1460), 50 !M 5,7-
dihydroxytryptamine (5,7-DHT, creatinine sulfate salt, Sigma-Aldrich),
and 20 !M (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid
(CPP). With the exception of CPP and IEM 1460, the pharmacological
agents used at the indicated concentrations do not to our knowledge
block glutamate receptors on AII or A17 amacrine cells. Solutions were
either made up freshly for each experiment or were prepared from con-
centrated aliquots stored at #20°C. Solutions with 5,7-DHT also con-
tained ascorbic acid (100 !M) as an antioxidant and were protected from
light.
In experiments with two-photon microscopy and Ca 2! imaging (see
below), we used high-resolution microiontophoresis (Murnick et al.,
2002) to activate glutamate receptors on A17 amacrine cells. High-
resistance pipettes (80 –90 M$) were pulled (P-97; Sutter Instrument)
from filamented borosilicate glass (outer diameter, 1.5 mm; inner diam-
eter, 0.86 mm) and filled with 150 mM glutamate (pH adjusted to 7.0 with
NaOH). Alexa Fluor 594 (40 !M) was added for visualization of the
pipette tip. The pipette capacitance was compensated by the microion-
tophoresis system (MVCS-C-02M; npi electronic). Brief (typically 0.6 –
1.0 ms), negative current pulses (typically 200 – 600 nA) were applied to
eject glutamate after the pipette tip was positioned close (1–2 !m) to
an A17 varicosity under visual control using two-photon microscopy.
Electrophysiological recording and data acquisition. Patch pipettes were
pulled from thick-walled borosilicate glass (outer diameter, 1.5 mm;
inner diameter, 0.86 mm). The open-tip resistance of the pipettes ranged
from 4.5 to 8.5 M$ when filled with intracellular solutions. Voltage-
clamp recordings were performed with an EPC9-dual, an EPC10-USB-
dual, or an EPC10-triple amplifier (HEKA Elektronik) controlled by
PatchMaster software. After establishing a G$-seal, currents caused by
the recording electrode capacitance (Cfast) were automatically measured
and neutralized by the amplifier. After breaking into the cell, currents
caused by the cell membrane capacitance (Cslow) were partially neutral-
ized by the amplifier. The sampling interval was set between 10 and 50 !s
depending on the experiment. Before sampling, signals were low-pass
filtered (analog 3- and 4-pole Bessel filters in series) with a corner fre-
quency (#3 dB) of 4 or 5 kHz. Cells with a holding current more negative
than #80 pA (at a holding potential of #60 mV) or a series resistance
(Rs) %30 M$ were rejected. For Ca
2! imaging experiments with A17
amacrines, series resistances "60 M$ were allowed.
During acquisition of spEPSCs, each epoch of continuous recording
had a duration of 30 s. Between each record, Rs was monitored by apply-
ing a series of 20 mV hyperpolarizing voltage pulses (16 ms duration)
after transiently disabling the Cslow neutralization circuitry of the ampli-
fier. The charging transients were analyzed on-line by FitMaster software
(HEKA Elektronik) by fitting the decay phase during the voltage pulse
with a double exponential function and Rs was calculated from the am-
plitude of the voltage pulse and the peak current amplitude extrapo-
lated to the onset of the pulse. After each 30 s epoch of continuous
recording, the data were exported to IGOR Pro (WaveMetrics) and
the frequency of spEPSCs was displayed throughout the recording
(spEPSCs were detected by routines written for IGOR Pro by T.
Ishikawa, Jikei University, Japan).
Experimental model of type 1 diabetes. Diabetes was induced in 4-week-
old rats with a single intraperitoneal injection of streptozotocin (65
mg/kg body weight), a toxin selective for # cells of the pancreatic islets.
Streptozotocin was freshly dissolved in 10 mM Na-citrate buffer, pH 4.5,
and stored at #20°C until immediately before use. After injection, each
rat was returned to its home cage and tested for development of diabetes
by measuring the blood glucose concentration 2 d later. Blood glucose
was measured with a hand-held glucometer (Contour or Contour XT
Glucometer, Bayer) by collecting a drop of blood from the tail. Rats with
blood glucose concentration exceeding 250 mg/dl were considered dia-
betic. At the day of the experiment, diabetes was again verified by mea-
suring blood glucose. Animals were kept on a 12 h light/dark cycle with
ad libitum access to food and water.
When rats received treatment with insulin (Sigma-Aldrich), diabetes
was first verified by measuring blood glucose 2 d after streptozotocin
injection and then insulin was administered subcutaneously twice every
day until the day of the experiment. During the first 2 d of insulin treat-
ment, glucose concentration was measured twice daily and the dose of
insulin was adjusted between 2 and 7 units to maintain the blood glucose
concentration lower than 250 mg/dl. After the third day of insulin treat-
ment, we found that administration of 6 units of insulin twice each day
resulted in adequate glucose levels and this treatment continued without
further adjustments until the day of the experiment. During this period,
blood glucose concentration was measured once daily, before the second
injection of insulin.
Analysis of electrophysiological data. Data were analyzed offline with
FitMaster, IGOR Pro, AxoGraph X (AxoGraph Scientific), Excel (Mi-
crosoft), MiniAnalysis (Synaptosoft), and GraphPad Prism (GraphPad
Software). For detection of spEPSCs with MiniAnalysis, the threshold
was set to 3– 8 pA depending on the noise level and detected events were
confirmed by eye. To quantify spEPSC amplitude reduction evoked by
IEM 1460, we used the method of largest amplitude count matching
(Stell and Mody, 2002). For kinetic analysis, we included only well sepa-
rated spEPSCs (interevent interval $10 ms) that appeared to rise in a
monophasic fashion to a peak followed by an exponential decay. Before
averaging, individual spEPSCs were aligned at the 50% rise time. The
decay time course of individual and averaged spEPSCs was estimated by
curve fitting with a single exponential function as follows:
I&t' % Aexp&& t/'' ( Iss (1)
where I(t) is the current as a function of time, A is the amplitude at time
0, ' is the time constant, and Iss is the steady-state current amplitude
(typically zero).
For peak-scaled, nonstationary noise analysis of spEPSCs (for review,
see Hartveit and Veruki, 2007), only well separated (interevent interval
%10 ms), monophasic (10 –90% rise time (1 ms) events were included.
The number of events included in the analysis for each cell ranged from
81 to 1215. The ensemble variance was calculated from the difference
current between each event and the ensemble mean. Before subtraction,
the peak of the ensemble mean was scaled to the corresponding value of
the spEPSC at the same point in time to correct for quantal and synaptic
variability. The ensemble variance was plotted against the ensemble
mean current (for the interval between the peak response and the end of
the decay phase) and fitted with the parabolic function as follows:
)2&I' % iI & I2/N ( )b
2 (2)
where ) 2( I) is the variance as a function of mean current, i is the appar-
ent single-channel current, N is the average number of open channels at
the spEPSC peak, and )b
2 is the variance of the background noise. The
apparent single-channel chord conductance (*) was then calculated as
follows:
* % i/&Vm & Erev' (3)
from the known holding potential (Vm) and assuming a current reversal
potential (Erev) of 0 mV.
For illustration purposes, most raw current records were low-pass
filtered (digital Gaussian filter, #3 dB at 500 Hz–2 kHz) or smoothed by
a binomial smoothing function (IGOR Pro) to emphasize the kinetics of
the response.
Wide-field fluorescence microscopy. In some experiments, we acquired
image stacks of cells filled with fluorescent dye (Alexa Fluor 488 or Alexa
Fluor 594), using a TILLvisION system (TILL Photonics). An image stack
was acquired as a series of optical sections collected at temporal intervals
of 500 ms and focal plane intervals of 0.5 !m, using a cooled, interline
transfer CCD camera (Imago QE). The excitation light source (Poly-
chrome V, 150 W xenon lamp) was coupled to the epifluorescence port of
the microscope with a custom-made condensor via a quartz fiber-optic
light guide. The wavelength of excitation light was 488 nm for Alexa
Fluor 488 and 570 nm for Alexa Fluor 594 and the exposure time was 50
ms. At the total magnification used, the pixel size was )106 nm in the
X-direction and )108 nm in the Y-direction. The fluorescence mirror
unit (U-MF2; Olympus) consisted of a dichroic mirror (T510LPXRXT
for Alexa Fluor 488; T585LP for Alexa Fluor 594), an excitation filter
(ET480/40x for Alexa Fluor 488; ET560/40x for Alexa Fluor 594), and an
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emission filter (ET535/50m for Alexa Fluor 488; ET630/75m for Alexa
Fluor 594), with all filters purchased from Chroma. After acquisition,
Huygens Essential (Scientific Volume Imaging) was used to remove noise
and reassign out-of-focus light by deconvolution with a theoretical
point-spread function (CMLE method). Maximum intensity projections
were generated with ImageJ software (NIH) that also enabled adjustment
of contrast, brightness, levels, and gamma (over the entire image).
Two-photon fluorescence microscopy and Ca2! imaging. Red (from Al-
exa Fluor 594) and green (from OGB-1) fluorescence for structural and
functional imaging, respectively, were imaged with the MOM equipped
with a computer-controlled, mode-locked, ultrafast-pulsed Ti:sapphire
laser (Mai Tai DeepSee, SpectraPhysics) tuned to 810 nm. Scanning was
performed by galvanometric scanners (MicroMax 673XX dual axis,
Cambridge Technology) and 3 mm mirrors (6210H, Cambridge Tech-
nology). Epifluorescence was detected by multialkali photomultiplier
tubes (R6357; Hamamatsu) and the analog signals were digitized by an
acquisition board (NI-6110E; National Instruments). The intensity of
the laser light was attenuated and controlled by an electro-optic modu-
lator (350 – 80LA with BK option; ConOptics) driven by a 302RM am-
plifier (ConOptics). Two-photon microscopy and image acquisition was
controlled by ScanImage software (v3.8.1; Pologruto et al., 2003). Image
stacks were acquired as a series of optical slices (512 " 512 or 1024 "
1024 pixels; 2–3 frames/slice) at focal plane intervals of 0.2 or 0.4 !m. For
imaging intracellular Ca 2! dynamics of A17 varicosities, we sampled
fluorescence (OGB-1) from individual varicosities in both line-scan (64
pixels/line, temporal resolution )960 Hz) and frame-scan mode (16 "
16 pixels, temporal resolution )25 Hz). Ca 2! imaging started 20 –30
min after establishing the whole-cell configuration to allow for maximal
indicator loading at A17 varicosities in stratum 5 (S5) of the IPL. Line-
scan and frame-scan imaging data were analyzed by custom routines
developed under IGOR Pro. Background fluorescence (Fb) was mea-
sured as the average signal from a rectangular area close to the region of
interest and baseline fluorescence (F0) was measured by averaging the
signal during a 250 – 800 ms interval before stimulus onset. For a given
signal ( F), the relative change in fluorescence related to a change in Ca 2!







and for simplicity referred to as *F/F.
Structural images were deconvolved with Huygens Essential. ImageJ
was used to generate maximum intensity projections and to adjust con-
trast, brightness, levels, and gamma (over the entire image).
Statistical analysis. Data are presented as mean + SEM (n , number of
cells or varicosities) with ranges either displayed by individual data
points in bar graphs or stated explicitly. Percentages are calculated as
percentage of control. Statistical analyses with comparisons between or
within groups were performed using Student’s two-tailed t test (paired
and unpaired as appropriate) or ANOVA. To test for differences among
groups, we obtained adjusted p values by Tukey’s or Sidak’s multiple-
comparison procedures for differences within one group (normal or
diabetic) and between two groups (normal vs diabetic), respectively.
Differences were considered statistically significant at the p ( 0.05 level.
The number of individual trials included in the averaged traces in the
figures is stated for each case.
Results
Targeting the RBC-AII-A17 microcircuit in rat retinal slices
The cellular elements and basic synaptic connectivity of the RBC-
AII-A17 microcircuit are illustrated schematically in Figure 1.
Cells were targeted for electrophysiological recording as de-
scribed in Materials and Methods. Whereas both AII and A17
amacrines receive glutamatergic input from RBCs (Kolb and Fa-
miglietti, 1974; Hartveit, 1999; Singer and Diamond, 2003;
Veruki et al., 2003; Chávez et al., 2006), they differ markedly in
their morphology (Fig. 1D,E). A17 amacrines are wide-field
amacrine cells and receive input from a large number of bipolar
cells (Nelson and Kolb, 1985; Grimes et al., 2010). In contrast, AII
amacrines are narrow-field amacrine cells with shorter processes
and consequently more amenable to high-resolution recording
of spEPSCs (Veruki et al., 2003). There were no obvious morpho-
logical differences between these three cell types in diabetic com-
pared with normal animals. Animals with diabetes were used for
experiments 24 + 1 d (range 18 –36) after injection with strepto-
zotocin. For our study, we used a total of 25 normal, 23 diabetic,
and three insulin-treated diabetic rats.
Increased frequency of spEPSCs in AII amacrines from
diabetic animals
To probe the dynamics and excitability of the individual micro-
circuit components, we first recorded glutamatergic spEPSCs
mediated by AMPARs in AII amacrines (Veruki et al., 2003) from
normal and diabetic animals (Fig. 2A–C). In normal animals
(Fig. 2B), the frequency of spEPSCs was 122 + 13 Hz (Fig. 2D;
n , 16 cells). In contrast, for diabetic animals (Fig. 2C) the fre-
quency was considerably higher at 238 + 20 Hz (Fig. 2D; n , 14
cells; F(2,35) , 16.01, p ( 0.0001, one-way ANOVA). In diabetic
rats successfully treated with insulin to normalize blood glucose
levels, the frequency of spEPSCs was 110 + 23 Hz (Fig. 2D; n , 8
cells), similar to that in normal animals (F(2,35) , 16.01, p ,
0.937, one-way ANOVA), suggesting that the increased spEPSC
frequency was related to development of diabetes and hyper-
glycemia. We did not observe any amplitude or kinetic differ-
ences between spEPSCs in AIIs from normal and diabetic
animals (Table 1).
Reduced GABAergic inhibition of presynaptic inputs to AII
amacrines from diabetic animals
The difference in frequency of spEPSCs in AII amacrines from
normal and diabetic animals, without a change in amplitude and
kinetic parameters, suggests a presynaptic mechanism. AII ama-
crines receive synaptic inputs from RBCs (Kolb and Famiglietti,
1974) and some types of OFF-cone bipolar cells (Kolb, 1979).
Because the input from RBCs is substantial (Strettoi et al., 1992),
we focused on the possibility that there could be a change in the
release from these cells in diabetic animals. An effect of diabetes
on exocytosis could be mediated by a direct effect on RBCs, or
alternatively, by reduced inhibitory input resulting in disinhibi-
tion. RBCs receive inhibitory input from wide-field GABAergic
amacrine cells (both reciprocal and nonreciprocal) and narrow-
field glycinergic amacrine cells (Eggers and Lukasiewicz, 2011).
To probe for differences in inhibitory input to the presynaptic
inputs to AII amacrines between normal and diabetic animals, we
examined the effect of blocking glycinergic and GABAergic neu-
rotransmission. Blocking glycine or GABAA receptors (GABAA-
Rs) had no effect on the frequency of spEPSCs in AII amacrines
from either normal or diabetic animals (Fig. 2E,F). However,
blocking GABAC receptors (GABACRs) markedly increased the
frequency of spEPSCs in AII amacrines from normal animals
(90 + 16 Hz in control vs 162 + 25 Hz after pharmacological
block; n , 4 cells; F(3,24) , 3.486, p , 0.0081, two-way ANOVA;
Fig. 2E). In contrast, blocking GABACRs had no effect on the
frequency of spEPSCs in AII amacrines from diabetic animals
(226 + 22 Hz in control vs 226 + 19 Hz after pharmacological
block; n , 6 cells; F(3,24) , 3.486, p % 0.999, two-way ANOVA;
Fig. 2F). After blocking GABACRs, there was no difference in
spEPSC frequency between AII amacrines from normal and dia-
betic animals (p , 0.111, two-way ANOVA). These results sug-
gested that baseline inhibition mediated by GABACRs on bipolar
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cells presynaptic to AII amacrines is markedly reduced in diabetic
animals.
Reduced release of GABA from A17 amacrines in
diabetic animals
The reduced tonic activation of GABACRs on bipolar input to AII
amacrines in diabetic animals could be mediated by reduced
GABACR efficacy or reduced release of GABA. However, RBCs
from animals with streptozotocin-induced diabetes display ro-
bust GABACR-mediated responses (Ramsey et al., 2006, 2007),
suggesting that the first possibility is less likely. GABACRs on
RBCs are activated by synaptic input from both reciprocal (A17)
and nonreciprocal amacrine cells (Hartveit, 1999; Chávez et al.,
2006, 2010; Eggers and Lukasiewicz, 2006, 2011). To distinguish
between these two inputs we used 5,7-DHT, a neurotoxin that
specifically eliminates input to RBCs from reciprocal A17 ama-
crines (Dong and Hare, 2003; Chávez et al., 2006), but not from
nonreciprocal amacrine cells (Chávez et al., 2010). For AII ama-
crines from normal animals, adding 5,7-DHT to the bath solu-
tion resulted in a significant increase of spEPSC frequency (Fig.
2G; 87 + 12 Hz, control; 120 + 16 Hz, 5,7-DHT; n , 11 cells,
F(1,15) , 9.557, p , 0.0122, two-way ANOVA), suggesting that
A17 amacrines mediate a baseline GABAergic inhibition of RBC
input to AII amacrines. In contrast, for AII amacrines from dia-
betic animals, there was no difference in spEPSC frequency after




Figure 2. Increased frequency of spEPSCs in AII amacrine cells from diabetic animals and involvement of A17 amacrine cells. A, Recording location (AII) in RBC-AII-A17 microcircuit. B, spEPSCs
(transient inward currents with fast kinetics) in an AII amacrine cell from a normal animal. To ensure that spEPSCs were not contaminated by glycine or GABAA receptor inputs or spontaneous action
currents, we performed the recordings in the presence of strychnine, bicuculline, and TTX (B, C). Here and in C, activity is displayed at both a slow (top trace) and a fast time scale (bottom trace; solid
horizontal line indicates period of top trace expanded in bottom trace). C, spEPSCs in an AII amacrine cell from a diabetic animal. Notice higher frequency of spEPSCs compared with B. D, Frequency
of spEPSCs (here and later, bars represent mean+SEM) in AII amacrine cells from normal animals (open bar; n ,16 cells), diabetic animals (light gray bar; n ,14 cells), and insulin-treated diabetic
animals (dark gray bar; n , 8 cells). Here and later, data from individual recordings are represented by circles and the results from statistical comparisons between averages are indicated by n.s. (no
significant difference; p % 0.05) and a single asterisk (statistically significant difference; p ( 0.05). E, Frequency of spEPSCs (n , 4 cells) in AII amacrine cells from normal animals. Here and later,
data points for the same cell are connected by lines. Four different recording conditions were tested sequentially: control (no pharmacological blockers added), TTX ! strychnine (to block
voltage-gated Na ! channels and glycine receptors), TTX! strychnine!bicuculline (to also block GABAA receptors), and TTX! strychnine!bicuculline!TPMPA (to also block GABAC receptors).
Only comparisons with statistically significant difference indicated. F, Frequency of spEPSCs (n , 6 cells) in AII amacrine cells from diabetic animals. As in E, four different recording conditions were
examined sequentially. Notice how blocking GABAC receptors increases spEPSC frequency in AII amacrines from normal, but not diabetic animals. G, Frequency of spEPSCs in AII amacrine cells, first
during a control condition (with TTX ! strychnine) and then after treatment with the neurotoxin 5,7-DHT to ablate A17 amacrine cells and their reciprocal inhibition of RBCs. Three different groups
of cells were tested with 5,7-DHT: normal (n , 11 cells), diabetic (n , 6 cells), and normal with pharmacologically blocked GABAC receptor-mediated inhibition (TPMPA; n , 4 cells). Notice how
ablating A17 amacrine cells increased the frequency of spEPSCs in AII amacrine cells from normal animals, but not from diabetic animals or from normal animals with pharmacologically blocked
GABAC receptor-mediated inhibition.
Table 1. Amplitude and kinetic parameters for spEPSCs in AII amacrine cells from
normal and diabetic animals
Normal (n , 16 cells) Diabetic (n , 9 cells) p (unpaired t test)
Peak amplitude 18 + 1 pA 21 + 1 pA 0.087
(11–28) (14 –27)
10 –90% rise time 433 + 20 !s 407 + 11 !s 0.383
(299 – 601) (351– 464)
'decay 1.01 + 0.05 ms 0.92 + 0.03 ms 0.192
(0.75–1.45) (0.80 –1.12)
spEPSCs recorded in the presence of the pharmacological blockers strychnine, bicuculline, and TTX. Data stated as
mean + SEM (range). Number of events averaged for each cell: 95–1013. Cells where a sufficient number of well
separated events could not be obtained were excluded.
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5,7-DHT; n , 6 cells, F(1,15) , 9.557, p , 0.308, two-way
ANOVA), suggesting that GABA release from A17 amacrines is
compromised in diabetic animals. Ascorbic acid was added as an
antioxidant to all solutions with 5,7-DHT, but had no effect on
the frequency of spEPSCs in AII amacrines (52 + 25 Hz, control;
57 + 27 Hz, ascorbic acid; n , 4 cells; p , 0.465, paired t test;
TTX and strychnine were present in both conditions).
When 5,7-DHT was applied after blocking GABACRs phar-
macologically, there was no change in the frequency of spEPSCs
in normal AII amacrines (Fig. 2G; 159 + 31 vs 162 + 37 Hz; n ,
4 cells, p , 0.822, paired t test). Correspondingly, the effect of
blocking GABACRs was occluded by prior treatment with 5,7-
DHT (101 + 24 vs 104 + 33 Hz, n , 4 cells, p , 0.867, paired t
test). Thus, the increased frequency of spEPSCs in AII amacrines
from diabetic animals can be attributed to reduced release of
GABA from A17 amacrines.
Reduced activation of GABACRs on RBCs in diabetic animals
Reduced release of GABA from A17 amacrines and reduced acti-
vation of GABACRs on bipolar cells presynaptic to AII amacrines
in diabetic animals suggest that RBCs are inhibited by baseline
activation of GABACRs in normal animals (similar to goldfish
bipolar cells; Hull et al., 2006; Palmer, 2006). To directly examine
whether GABACR-mediated inhibition is reduced by diabetes, we
recorded from RBCs in normal and diabetic animals (Fig. 3A). To
increase the driving force for chloride-mediated currents without
cell depolarization (that in itself could perturb the microcircuit
dynamics), we recorded with an intracellular solution with high
chloride concentration such that the chloride equilibrium poten-
tial (ECl) was )0 mV (Vhold , #60 mV). After recording the
holding current (Ihold) continuously for 10 min, we blocked
GABACRs pharmacologically. In RBCs from normal animals, this
evoked an outward current in all cells tested (Fig. 3B,D; average
change in Ihold 5.5 + 1.3 pA; n , 10 cells; Ihold averaged over 5 s
epochs). In contrast, for RBCs from diabetic animals, blocking
GABACRs had no effect on Ihold (Fig. 3C,D; average change
#0.8 + 0.6 pA; n , 9 cells; p , 0.0005, unpaired t test). This
supports our hypothesis that diabetes reduces release of GABA
from A17 amacrines and thereby reduces the tonic activation of
GABACRs on RBCs.
Increased frequency of spEPSCs in A17 amacrines in
diabetic animals
If the increased frequency of glutamatergic spEPSCs in AII ama-
crines from diabetic animals is predominantly mediated by in-
creased release of glutamate from RBCs, this predicts a similar
increase in frequency of spEPSCs in A17 amacrines. Recordings
of spEPSCs in A17 amacrines (Fig. 4A) were overall noisier than
for AII amacrines (Fig. 4B,C), presumably reflecting overlapping
synaptic input that could not be adequately resolved because of
high frequency and electrotonic filtering of bipolar cell inputs
spread across the length of thin processes that extend hundreds of
!m from the cell body (Nelson and Kolb, 1985; Grimes et al.,
2010). Nevertheless, the frequency of spEPSCs was significantly
higher in A17 amacrines from diabetic (51 + 8 Hz, n , 10 cells)
compared with normal animals (28 + 5 Hz, n , 10 cells; p ,
0.0336, unpaired t test; Fig. 4D). We did not observe any ampli-
tude or kinetic differences between spEPSCs in A17s from nor-
mal and diabetic animals (Table 2).
Diabetes changes the pharmacological properties of spEPSCs
in A17 but not AII amacrines
The release of GABA from A17 amacrines can be driven by influx
of Ca 2! through CP-AMPARs (Chávez et al., 2006). Accordingly,
one possible explanation for reduced release of GABA in diabetic
animals is a change in AMPAR subunit composition that reduces
Ca 2! permeability. A change in subunit composition could be
accompanied by differences in pharmacological properties
(Traynelis et al., 2010). To investigate this, we examined the effect





Figure 3. Blocking GABAC receptor-mediated inhibition evokes an outward current in RBCs
from normal, but not from diabetic animals. A, Recording location (RBC) in RBC-AII-A17 micro-
circuit. B, Continuous voltage-clamp recording of RBC from normal animal and outward shift of
holding current evoked by application of the GABAC receptor antagonist TPMPA. Here and in C,
we recorded with symmetrical chloride concentrations (ECl , 2.7 mV) to increase the driving
force for chloride (Vhold , #60 mV). C, Continuous voltage-clamp recording of RBC from
diabetic animal and no change in holding current evoked by application of TPMPA. D, Average
change in holding current (*Ihold; mean + SEM) evoked by TPMPA in RBCs from normal (open
bar; n , 10 cells), and diabetic (light gray bar; n , 9 cells) animals. Positive and negative
values correspond to outward and inward currents, respectively.
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1460 is a voltage-dependent open-channel blocker of AMPARs
with a lower IC50 for GluA2-lacking receptors than for GluA2-
containing receptors (Magazanik et al., 1997; Buldakova et al.,
1999). For spEPSCs in A17 amacrines, IEM 1460 reduced the
amplitude in both normal and diabetic animals, but spEPSCs in
diabetic animals were more resistant to IEM 1460 than spEPSCs
in normal animals. This is illustrated by the examples in Figure
5A of average spEPSCs in A17 amacrines from a normal (left) and
a diabetic animal (right). On average, the IEM-resistant current
in diabetic animals was 56 + 6% (n , 4 cells) of the correspond-
ing control value, significantly larger than in normal animals
(39 + 1%, n , 5 cells; p , 0.0128, unpaired t test; Fig. 5B).
In contrast, for AII amacrines, IEM 1460 reduced the ampli-
tude of spEPSCs equally in normal and diabetic animals (Fig.
5C,D). On average, the IEM-resistant current in AII amacrines
from diabetic animals was 54 + 8% (n , 4 cells) of the corre-
sponding control value and in AII amacrines from normal ani-
mals it was 59 + 4% (n , 5 cells; p , 0.592, unpaired t test; Fig.
5D). This suggested that diabetes induced a change in the subunit
composition of synaptic AMPARs in A17, but not AII amacrines.
Diabetes reduces the single-channel conductance of synaptic
AMPARs in A17 but not in AII amacrines
A change in the subunit composition that decreases the Ca 2!
permeability of the AMPARs is likely to be accompanied by a
reduction of the single-channel conductance (Swanson et al.,
1997). Due to fast ion channel kinetics and electrotonic filtering,
it is not possible to estimate the single-channel conductance of
synaptic AMPARs by directly resolving channel openings in the
decay phase of spEPSCs, but nonstationary noise analysis can be
a valuable tool for investigating changes in synaptic properties
related to development, plasticity, and disease processes (Hart-
veit and Veruki, 2007). Thus, although the accuracy of the ob-
tained single-channel conductance might be limited, a
comparison between conditions, with all other factors being con-
stant, can provide valuable mechanistic information.
Peak-scaled nonstationary noise analysis of spEPSCs recorded
in A17 amacrines revealed that the single-channel conductance
was lower in cells from diabetic animals (Fig. 5E,F). For A17
amacrines from diabetic animals, the average was 8.6 + 0.8 pS
(n , 5 cells; Fig. 5G), significantly lower than for A17 amacrines
from normal animals (12.6 + 0.4 pS, n , 5 cells; p , 0.0015,
unpaired t test; Fig. 5G). Because the peak scaling yielded skewed,
as opposed to parabolic, variance versus mean curves (Hartveit
and Veruki, 2007), we repeated the analysis without peak scaling.
In this case, the variance versus mean curves deviated strongly
upward (Fig. 5E,F), but the initial slope of the curves corre-
sponds to the unitary current amplitude (Hartveit and Veruki,
2007) and gave very similar results to the analysis with peak scal-
ing. In contrast to A17 amacrines, for the AII amacrines there was
no difference in the single-channel conductance for spEPSCs in
cells from normal (16.9 + 1.7 pS, n , 6 cells; Fig. 5H) and
diabetic animals (20.8 + 3.8 pS, n , 4 cells; p , 0.321, unpaired
t test; Fig. 5H).
Diabetes reduces glutamate-evoked Ca 2! influx through
AMPARs on A17 varicosities
The observed changes of pharmacological properties and single-
channel conductance of AMPARs of A17 amacrines in diabetic
animals suggest, but do not by themselves demonstrate reduced
Ca 2! permeability. To directly investigate this, we combined mi-
croiontophoretic application of glutamate and two-photon Ca 2!
imaging of A17 varicosities (Grimes et al., 2009; Fig. 6A). Two-
photon microscopy allowed targeting of fine-tipped pipettes
(filled with 150 mM glutamate) to individual varicosities (Fig.
6B,C). When the pipette tip was in close apposition to a varicos-
ity, application of brief (0.6 –1 ms) pulses of glutamate evoked
transient inward currents (Fig. 6D,E). In the varicosity illustrated
in Figure 6B, the glutamate-evoked current was accompanied by
an increase in Ca 2!, measured as an increase in the relative fluo-
rescence of OGB-1 (*F/F; Fig. 6D). For five A17 varicosities
(from 2 cells) from normal animals, the average peak inward





Figure 4. Frequency of spEPSCs in A17 amacrine cells is higher in diabetic than normal
animals. A, Recording location (A17) in RBC-AII-A17 microcircuit. B, spEPSCs in an A17 amacrine
cell from a normal animal. C, spEPSCs in an A17 amacrine cell from a diabetic animal. Notice
higher frequency of spEPSCs compared with B. D, Frequency of spEPSCs in A17 amacrine cells
from normal (open bar; n , 10 cells) and diabetic (light gray bar; n , 10 cells) animals.
Table 2. Amplitude and kinetic parameters for spEPSCs in A17 amacrine cells from
normal and diabetic animals
Normal (n , 10 cells) Diabetic (n , 10 cells) p (unpaired t test)
Peak amplitude 5.2 + 0.4 pA 5.4 + 0.3 pA 0.620
(3.4 – 6.7) (3.7– 6.9)
10 –90% rise time 562 + 26 !s 548 + 25 !s 0.709
(471–730) (452– 668)
'decay 1.66 + 0.15 ms 1.54 + 0.04 ms 0.433
(1.07–2.41) (1.31–1.66)
spEPSCs recorded in the presence of the pharmacological blockers strychnine, bicuculline, TPMPA, and TTX. Data
stated as mean + SEM (range). Number of events averaged for each cell: 483–1361.
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increase of Ca 2! was 65 + 19% (Fig. 6G).
In contrast, when similar experiments
were performed with A17 varicosities
from diabetic animals, four of six varicos-
ities (from 4 cells) displayed Ca 2! signals
(10% (Fig. 6E), with an average maxi-
mum increase of 10 + 2% (Fig. 6G),
significantly smaller than for normal var-
icosities (p , 0.0111, unpaired t test).
This strongly suggests decreased Ca 2!
permeability of AMPARs in A17 ama-
crines from diabetic animals. All six A17
varicosities displayed an inward current in
response to glutamate (8.8 + 1.5 pA), not
significantly different from varicosities
from normal animals (p , 0.107, un-
paired t test; Fig. 6F).
To ensure that the small Ca 2! re-
sponses in A17 varicosities from diabetic
animals were not explained by baseline
saturation of OGB-1, we examined the re-
sponse to depolarizing voltage steps (from
Vhold to 0 mV; cf. Grimes et al., 2009). In
eight of nine A17 varicosities from dia-
betic animals there was a clear Ca 2! signal
(120 + 27%; n , 8 varicosities from 5
cells), strongly suggesting that there was
not a problem with indicator dye satura-
tion in diabetic animals. The presence of
Ca 2! responses mediated via depolarizing
voltage steps and activation of voltage-
gated Ca 2! channels (Grimes et al., 2009)
also suggests that putative Ca 2! signals
mediated by direct depolarization of A17
varicosities by the microiontophoretic pi-
pette were not a problem, given the small
Ca 2! responses evoked by microionto-
phoretic application of glutamate in the
diabetic animals.
There were no obvious morphological
differences between A17 varicosities in di-
abetic compared with normal animals. It
is difficult to exclude the possibility that
such changes could occur, however, espe-
cially with diabetes of longer duration
than in our study. Further investigations
of these questions will require high-
resolution structural imaging in slices or
in whole-mounts.
Discussion
An understanding of the early dysfunc-
tion of the neural retina that precedes the
microvascular pathology characteristic of
later stages of diabetic retinopathy has
been hampered by the lack of appropriate
cellular models in which to identify spe-
cific functional changes at the molecular
and cellular level. Differences in method-
ologies and experimental models have
precluded consistent interpretation and
leave open the identity of specific retinal





Figure 5. Altered pharmacological and biophysical properties of spEPSCs from A17, but not AII amacrine cells in diabetic
animals. A, Average spEPSCs recorded from two A17 amacrine cells (inset), one from a normal animal (left), in control condition
(dashed line; n , 266 events) and in the presence of the open-channel AMPA receptor blocker IEM 1460 (continuous line; n , 252
events) and one from a diabetic animal (right), in control condition (dashed line; n , 106 events) and in the presence of IEM 1460
(continuous line; n , 67 events). Amplitudes of spEPSC waveforms have been normalized relative to the control waveform and
only well separated events were included in the illustrated averages (A, C). Notice the smaller suppression by IEM 1460 in the
diabetic animal. B, Proportion of average spEPSC peak amplitude resistant to IEM 1460 in A17 amacrine cells from normal (n , 5
cells) and diabetic (n , 4 cells) animals. Notice larger fraction of IEM 1460-resistant current in cells from diabetic animals. C,
Average spEPSCs recorded from two AII amacrine cells (inset), one from a normal animal (left), in control condition (dashed line;
n , 366 events) and in the presence of IEM 1460 (continuous line; n , 222 events), and one from a diabetic animal (right), in
control condition (dashed line; n , 214 events) and in the presence of IEM 1460 (continuous line; n , 143 events). Notice similar
suppression by IEM 1460 in the normal and diabetic animals. D, Proportion of average spEPSC peak amplitude resistant to IEM 1460
in AII amacrine cells from normal (n , 5 cells) and diabetic (n , 4 cells) animals. No statistically significant difference
between cells from normal and diabetic animals with respect to degree of block by IEM 1460. E, Plots of ensemble current
variance versus mean current for 348 spEPSCs recorded in an A17 amacrine cell from a normal animal, calculated with (left)
or without (right) peak-scaling (see Materials and Methods). Here and in F, the data points have been fitted with Eq. 2 (left)
or a straight line (right; data points corresponding to the initial slope used for fitting). F, Plots of ensemble current variance
versus mean current for 545 spEPSCs recorded in an A17 amacrine cell from a diabetic animal, calculated with (left) or
without (right) peak-scaling. G, Average single-channel conductance estimated by nonstationary noise analysis of spEPSCs
in A17 amacrine cells from normal (n , 5 cells) and diabetic (n , 5 cells) animals. Notice lower single-channel conduc-
tance in diabetic animals. H, Average single-channel conductance estimated by nonstationary noise analysis of spEPSCs in
AII amacrine cells from normal (n , 6 cells) and diabetic (n , 4 cells) animals. Notice similar single-channel conductance
for cells from normal and diabetic animals.
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promised in early diabetes. The RBC-AII-A17 microcircuit is
structurally and functionally well characterized, plays a crucial
role in visual processing (Diamond and Grimes, 2014), and all
three of the constituent cell types are readily accessible and iden-
tifiable in the retinal slice preparation (Fig. 1). Whereas AII ama-
crines convey signals to ON- and OFF-cone bipolar cells via
electrical and chemical synapses (for review, see Hartveit and
Veruki, 2012), the only output of the A17 amacrine is back onto
the RBCs from which it received excitatory inputs (Nelson and
Kolb, 1985). Thus, this microcircuit, along with increasing in-
sight into its biophysical operational characteristics (Grimes et
al., 2009, 2010), provides a unique model in which to investigate
functional consequences of diabetes-evoked changes in signaling
molecules of retinal neural circuitry.
By probing the functional state and dynamics of the individual
microcircuit elements via electrophysiological recording of glu-
tamatergic spEPSCs and two-photon imaging of glutamate-
evoked Ca 2! signals, we have provided strong evidence for
reduced Ca 2! permeability of non-NMDA receptors on A17
amacrines in diabetic animals. As Ca 2! influx via CP-AMPARs
can mediate release of GABA from these cells (Chávez et al.,
2006), the reduced Ca 2! permeability in diabetic animals leads to
disinhibition of RBCs via reduced tonic activation of GABACRs.
The result is an increased release of glutamate from RBCs in
diabetic rats (Fig. 7).
Circuit elements involved in the increased glutamatergic
input to AII and A17 amacrine cells
We interpret the increased frequency of spEPSCs in AII ama-
crines as reflecting increased glutamate release from RBCs. This
does not exclude input from OFF-cone bipolar cells which can be
presynaptic at the lobular appendages of AII amacrines (for re-
view, see Demb and Singer, 2012), but two findings suggest that
input from RBCs makes a significant contribution. First, in-
creased frequency of spEPSCs was also detected in A17 amacrines
and these cells are thought to receive the majority, potentially all,
of their glutamatergic input from RBCs (Nelson and Kolb, 1985).
Second, the neurotoxin 5,7-DHT substantially decreases or elim-
inates output from A17 amacrines (Chávez et al., 2006), which
seem to exclusively direct their output to rod, as opposed to cone,
bipolar cells (Nelson and Kolb, 1985), while leaving lateral (non-
reciprocal) inhibitory mechanisms intact (Chávez et al., 2010).
Accordingly, when 5,7-DHT evokes an increase in spEPSCs in
AII amacrines in normal, but not in diabetic animals, this
strongly suggests increased glutamate release from RBCs.
An alternative explanation for enhanced glutamate release
from RBCs in diabetic animals is reduced sensitivity of GABARs
on these cells. However, recordings from acutely isolated RBCs
indicate that diabetes increases the sensitivity of GABACRs on
these cells (Ramsey et al., 2006, 2007), and our results suggest that
this increased sensitivity could reflect homeostatic synaptic plas-
ticity and compensation for reduced release of GABA from A17
amacrines.
Plasticity of CP-AMPARs in the RBC-AII-A17 microcircuit
There is evidence for expression of CP-AMPARs by both A17 and
AII amacrines. For A17s, the feedback inhibition triggered by
depolarization-evoked glutamate release from RBCs can be sup-
pressed by antagonists that are selective for CP-AMPARs (Chávez
et al., 2006) and glutamate release from RBCs evokes postsynap-
tic Ca 2!-influx in A17 varicosities through non-NMDA recep-
tors (Grimes et al., 2009). For AII amacrine cells, there is evidence
for somatic extrasynaptic AMPARs with relatively high Ca 2!
permeability (Mørkve et al., 2002), agonist-evoked uptake of
Co 2! through non-NMDA receptors (Osswald et al., 2007) and
inward rectification of the I–V relationship for synaptic currents
mediated by RBCs (Singer and Diamond, 2003).
There is strong evidence for activity-dependent regulation of
CP-AMPARs in a number of different CNS synapses, with the
parallel fiber input to stellate cells in the cerebellar cortex as the
best studied case (Cull-Candy et al., 2006). Increased afferent
activity increases the proportion of GluA2 subunits in synaptic
Figure 6. Reduced Ca 2! influx through non-NMDA receptors on A17 amacrine cell varicos-
ities in diabetic animals. A, A17 amacrine cell filled with Alexa Fluor 594 via patch pipette.
Maximum intensity projection (along z-axis) generated from two-photon fluorescence image
stack after deconvolution (A–C). Scale bar, 20 !m. B, C, Varicosities from two A17 amacrine
cells (B, normal, maximum intensity projection of image stack; C, diabetic, single focal plane)
filled with Alexa Fluor 594 and the Ca 2! indicator dye Oregon Green 488 BAPTA-1 and targeted
by fine-tipped pipettes (right) filled with glutamate and Alexa Fluor 594. Scale bars, 2 !m. D,
Current (top) and Ca 2! (bottom) signals in response to brief microiontophoretic pulses of
glutamate (#400 nA for 1 ms; vertical arrows) applied to varicosity in B (from normal animal).
NMDA receptors blocked by CPP added to the extracellular solution (D, E). Each trace, average of
five trials (D, E). E, Current (top) and Ca 2! (bottom) signals in response to brief microiontopho-
retic pulses of glutamate (#600 nA for 1 ms; vertical arrows) applied to varicosity in C (from
diabetic animal). F, G, Peak amplitude of current (F ) and Ca 2! signals (G) in response to brief
microiontophoretic pulses of glutamate to varicosities from A17 amacrines in normal (n , 5
varicosities) and diabetic animals (n , 6 varicosities).
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receptors, expressed as reduced rectification of the I–V relation-
ship and presumably reduced Ca 2! permeability. Reduced affer-
ent activity leads to the opposite effect, with a decreased
proportion of GluA2 and increased rectification. If a similar
mechanism is operative in the synapse between RBCs and A17 ama-
crines, it could amplify any perturbation of the normal homeostasis.
Regardless of whether the primary disturbance involves the CP-
AMPARs of A17 amacrines or the exocytotic machinery of RBCs,
decreased release of GABA from the A17 amacrines could trigger
a positive feedback mechanism where disinhibition and in-
creased glutamate release from RBCs leads to reduced Ca 2! per-
meability and reduced GABA release from the A17s.
Plasticity at glutamatergic synapses in both physiological and
pathological conditions is, at least partly, mediated by dynamic
membrane trafficking of AMPARs, with cytoskeletal structures in
the postsynaptic density (PSD) playing a role (Hanley, 2014).
Several studies have demonstrated a differential distribution of
PSD proteins at the RBC to A17-AII dyad synapse (Koulen et al.,
1998a, b; Ghosh et al., 2001; Brandstätter et al., 2004), with
PSD-95 localizing to the AII amacrine cell and glutamate
receptor-interacting protein (GRIP) localizing to the A17 ama-
crine (Ghosh et al., 2001; Fig. 7). Our results suggest that the
AMPARs on A17 amacrines are altered in early diabetes, whereas
those on AII amacrines are not and the differential distribution of
PSD proteins on these two cells could play a determining role. In
particular, GRIP has been implicated in control of Ca 2! perme-
ability of AMPARs at cerebellar synapses (Liu and Cull-Candy,
2005) and could potentially play a similar role at retinal syn-
apses. It will be important to see whether the proposed
diabetes-evoked changes of synaptic glutamate receptors and
PSD proteins can be verified by immunoelectron microscopy
that has the potential to examine the protein expression at the
ultrastructural level in all elements of the RBC-AII-A17
microcircuit.
Which mechanisms lead to abnormal
regulation of receptors and
circuit dynamics?
Previous work has suggested that high
glucose, both in vitro and in vivo, alters the
protein levels of specific types of gluta-
mate receptor subunits in retinal neurons.
Exposure of retinal cell cultures to ele-
vated concentrations of glucose increases
the expression of the GluA2 subunit (San-
tiago et al., 2006) and there is evidence for
an increase of the GluA2 subunit in reti-
nas of diabetic rats and humans (Santiago
et al., 2008; Semkova et al., 2010). The
changes we observed by electrophysiolog-
ical recordings from RBCs and AII and
A17 amacrine cells are consistent with and
can be explained by increased content of
GluA2 in synaptic receptors of A17 ama-
crines. In the recordings of spEPSCs from
A17 amacrines, this was detected as a re-
duction of the apparent single-channel
conductance and a decreased sensitivity to
the pharmacological blocker IEM 1460,
suggesting increased content of GluA2
and predicting reduced Ca 2! permeabil-
ity. However, there are no obvious candi-
dates among the many biochemical
processes thought to be affected by dia-
betic hyperglycemia (Antonetti et al., 2012; Simó and Hernández,
2014) for directly evoking a change in subunit composition of
glutamate receptors. Alternatively, a change in subunit composi-
tion could be mediated by normal mechanisms of plasticity in
response to perturbed release of glutamate resulting from distur-
bances in presynaptic Ca 2! dynamics and homeostasis (for re-
view, see Verkhratsky and Fernyhough, 2008). The ability of
insulin to counteract the effects evoked by streptozotocin argues
against a direct effect of streptozotocin on the neural retina,
which suggests instead that hyperglycemia plays a causative role.
Nevertheless, it has to be considered that the changes in synaptic
transmission and circuit dynamics could be directly related to a
lack of insulin, as retinal tissue, similar to other areas of the CNS,
is directly sensitive to insulin (Reiter and Gardner, 2003).
Can the observed changes at the level of the RBC-AII-A17
microcircuit explain visual disturbances observed in early
diabetic retinopathy?
The primary importance of the present results is threefold. First,
our results indicate that diabetes-evoked changes in glutamate
receptor subunit composition can be localized to specific syn-
apses in the intact retina. Similar changes could occur in synapses
and microcircuits elsewhere in the retina and CNS in response to
early diabetes. Second, the observed changes occur at a very early
time point, earlier than several other functional changes that have
been reported in the retina. Finally, our results demonstrate
changes in synaptic transmission and circuit dynamics that are
likely to translate to altered signal processing. Early signs of dia-
betic retinopathy, before microvascular pathology, include re-
duced contrast sensitivity and color vision abnormalities (Daley
et al., 1987; Lopes de Faria et al., 2001; Reis et al., 2014), which are
difficult to relate to specific retinal microcircuits. However, both
clinical and experimental studies have found evidence for
changes in electroretinogram (ERG) oscillatory potentials (Sakai
Figure 7. Changes in the RBC-AII-A17 microcircuit in early diabetes. Left, The microcircuit under normal conditions, where
glutamate released from the RBC acts on Ca 2!-permeable AMPARs (CP-AMPARs) on the A17 and AII amacrines. Ca 2! influx leads
to the release of GABA from the A17 and subsequent inhibitory feedback to the RBC. Right, The microcircuit in diabetes, with
modified dynamics, such that reduced Ca 2! permeability of the AMPARs on the A17 results in decreased release of GABA, reduced
inhibitory feedback and increased release of glutamate from the RBC (CI-AMPARs , Ca 2!-impermeable AMPARs).
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et al., 1995; Hancock and Kraft, 2004; Bearse et al., 2006), which
point to changes in inner retina signal processing and potentially
an involvement of A17 amacrines. There is evidence that these
ERG abnormalities are most prominent and consistent under
scotopic conditions, suggesting a higher susceptibility of rod
pathways (Aung et al., 2013; Pardue et al., 2014). Specifically,
reduced activation of GABACRs at RBC axon terminals could
result in reduced dynamic range of scotopic visual responses
(Dong and Hare, 2003; Herrmann et al., 2011) and reduced visual
sensitivity (Diamond and Grimes, 2014). In a wider perspective,
the current results underscore the importance of bridging the gap
between specific molecular pathologies and the resulting func-
tional consequences at the levels of microcircuits, networks, and
global function.
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tochemical localization of the postsynaptic density protein PSD-95 in the
mammalian retina. J Neurosci 18:10136 –10149. Medline
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